Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The 2018 guideline for PCOS suggests new diagnostic criteria and treatments, but recognizes the need for more research.

PCOD causes hormonal imbalances and infertility, requiring early diagnosis and treatment.

Doctors should know how to diagnose and treat PCOS, which often involves checking for high male hormone levels and using medications to manage symptoms.

The document concludes that effectively managing PCOS requires a multifaceted approach.

Polycystic Ovary Syndrome (PCOS) affects 6%-15% of women of reproductive age, causing symptoms like acne and hair loss, and increasing the risk of type 2 diabetes and heart disease; it's managed through diet, exercise, and medications like Metformin and hormonal contraceptives.

The document concludes that hirsutism is the main sign for diagnosing hyperandrogenism, which requires a detailed patient history and physical exam.

A man fainted and felt unwell after using a strong hair growth product, but got better when he stopped using it.

PCOS negatively affects women's quality of life, especially if not detected early.

Renaming frontal fibrosing alopecia to a syndrome could improve diagnosis and treatment.

Anticancer drugs are increasingly found in surface waters, and their long-term environmental effects are not well understood, requiring better testing methods.

Women with PCOS have lower adiponectin hormone levels and are more likely to have insulin resistance.

Free Testosterone Index, bioavailable testosterone, and androstenedione are the most accurate for diagnosing excess male hormones in PCOS.

Doctors need to be better prepared to assess and treat obesity in patients.

Women with PCOS risk had normal height and blood tests but higher weight and common acne or hirsutism.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

Hormones like estrogen, testosterone, progesterone, and prolactin play complex roles in female sexual function, with testosterone potentially improving sexual desire, arousal, and satisfaction. However, more research is needed to establish safe and effective hormone treatments for female sexual dysfunction.

Dutasteride does not impair mental function in elderly men with enlarged prostate.

New hormonal treatments for enlarged prostate show promise for safer, effective non-surgical options.

Skin problems can be signs of hormone-related disorders and recognizing them early is important for treatment.

Some breast cancer patients on hormone therapy experience hair loss, and treatments like certain topical inhibitors and supplements may help without harming their cancer prognosis.

High testosterone levels in 20% of the women studied may indicate PCOS, while 80% had low levels with potential health impacts.

PCOS is linked to low-grade chronic inflammation.

JSLE patients often have more hormone and metabolism issues, so regular check-ups and preventing obesity can help.

The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.

Women with PCOS should be screened for heart disease risk and manage their health to prevent it.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

The document recommends using both clinical evaluation and various measurement methods to assess skin greasiness, considering factors like temperature and hormones.

People with diabetes or obesity should manage their conditions carefully as they have a higher risk of severe COVID-19.

Hormones and genetics affect hair growth and patterns, with some changes reversible and others not.

Hair loss from hormone therapy in breast cancer patients can be improved with minoxidil treatment.